TriNetX moves to new headquarters in Cambridge, MA after outgrowing space
TriNetX has completed a yearlong project to expand its space from 8,200 to a 20,000 square feet in response to industry demand for its clinical trial services.
TriNetX has completed a yearlong project to expand its space from 8,200 to a 20,000 square feet in response to industry demand for its clinical trial services.
Vetter has begun an expansion of its secondary packaging capacities that will increase its facility by approximately 32,000 square feet.
Fraunhofer is “redoubling” its efforts to develop new antibiotics and transfer research into clinical trials through a project available to external partners for development.
Vince & Associates Clinical Research is conducting a Phase Ib alcohol interaction study of Amygdala Neurosciences’ ANS-6637 for the potential treatment of substance abuse.
Recipharm has installed serialization technology at its contract production facility in Lisbon, Portugal citing impending US and EU rules as a driver for the investment.
Q&A from CPhI Worldwide Frankfurt 2017
Mutual inspection report recognition is positive, but EU and US FDA alignment on product specs and compendia would help drug firms, says regulatory expert Ajaz Hussain.